Allscripts Healthcare Solutions Inc (MDRX) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 418.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,627 shares of the software maker’s stock after purchasing an additional 29,558 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Allscripts Healthcare Solutions were worth $521,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MDRX. Bank of Montreal Can increased its position in Allscripts Healthcare Solutions by 6.9% during the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock worth $135,000 after buying an additional 689 shares in the last quarter. LS Investment Advisors LLC increased its position in Allscripts Healthcare Solutions by 16.8% during the second quarter. LS Investment Advisors LLC now owns 14,925 shares of the software maker’s stock worth $190,000 after buying an additional 2,150 shares in the last quarter. Louisiana State Employees Retirement System increased its position in Allscripts Healthcare Solutions by 3.7% during the second quarter. Louisiana State Employees Retirement System now owns 47,300 shares of the software maker’s stock worth $604,000 after buying an additional 1,700 shares in the last quarter. Aperio Group LLC increased its position in Allscripts Healthcare Solutions by 149.4% during the second quarter. Aperio Group LLC now owns 40,290 shares of the software maker’s stock worth $514,000 after buying an additional 24,134 shares in the last quarter. Finally, State Treasurer State of Michigan increased its position in Allscripts Healthcare Solutions by 2.0% during the second quarter. State Treasurer State of Michigan now owns 74,800 shares of the software maker’s stock worth $954,000 after buying an additional 1,500 shares in the last quarter.

In other news, SVP James Hewitt sold 36,796 shares of the firm’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $14.11, for a total transaction of $519,191.56. Following the sale, the senior vice president now owns 181,766 shares in the company, valued at $2,564,718.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brian Farley sold 5,000 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total value of $67,600.00. Following the sale, the executive vice president now owns 196,607 shares in the company, valued at approximately $2,658,126.64. The disclosure for this sale can be found here. Insiders have sold 71,796 shares of company stock worth $992,992 in the last 90 days. Insiders own 0.91% of the company’s stock.

Shares of Allscripts Healthcare Solutions Inc (MDRX) opened at $14.19 on Tuesday. Allscripts Healthcare Solutions Inc has a fifty-two week low of $10.19 and a fifty-two week high of $14.51. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.20. The stock has a market capitalization of $2,553.02, a price-to-earnings ratio of 32.86, a PEG ratio of 2.52 and a beta of 1.34.

Several equities analysts have weighed in on the company. Citigroup raised their price target on Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Monday, August 7th. Cantor Fitzgerald reissued a “buy” rating and set a $17.00 price target (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Monday, August 14th. Robert W. Baird reissued a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. Royal Bank Of Canada assumed coverage on Allscripts Healthcare Solutions in a research report on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price target for the company. Finally, Zacks Investment Research raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and eleven have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $15.06.

COPYRIGHT VIOLATION WARNING: “Allscripts Healthcare Solutions Inc (MDRX) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank” was originally reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://transcriptdaily.com/2017/12/05/allscripts-healthcare-solutions-inc-mdrx-shares-bought-by-zurcher-kantonalbank-zurich-cantonalbank.html.

Allscripts Healthcare Solutions Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply